Zheng Ke, Mao Jingxin
Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chongqing Medical and Pharmaceutical College, Chongqing, China.
Clin Med Insights Oncol. 2024 Oct 12;18:11795549241287085. doi: 10.1177/11795549241287085. eCollection 2024.
Hashimoto thyroiditis (HT) combined with papillary thyroid cancer (PTC) is more common in clinical practice, maybe posing a serious threat to the health of patients. It is uncertain whether HT is a risk factor or protective factor for PTC. The aim of the study was to retrospectively explore the effect of HT on the biological behavior of PTC.
A total of 200 patients were included in the study. Among them, 100 patients with PTC without HT were in the control group (PTC group), and 100 cases diagnosed as PTC with HT were in the experimental group (HT + PTC group). The following data were counted and analyzed, respectively: (1) the basic clinicopathologic characteristics of patients; (2) postoperative thyroid function indicators; (3) blood biochemical indicators; (4) liver function indicators; and (5) histopathological report.
Compared with the PTC group, women were predominant in the PTC + HT group ( < .05). In addition, the central lymph node metastasis rate, the number of cervical lymph node metastases, and the lateral cervical lymph node metastasis rate were significantly decreased ( < .05). Thyroid peroxidase antibody (TPOAb), thyroid-stimulating hormone (TSH), and thyroglobulin antibody (TGAb) of the thyroid function index were significantly increased, while the thyroglobulin (TG) value was significantly decreased ( < .05). The alkaline phosphatase (ALP) level of the liver function index was significantly decreased, while the lactate dehydrogenase (LDH) level was significantly increased ( < .05). In the pathological examination, a large number of mononuclear cells infiltrated in the lymphocyte follicular stroma. In an ultrasound examination, the boundary definition rate is lower.
Women may be more susceptible to PTC or PTC and HT than men. Patients under 55 years old accounted for a larger proportion in PTC + HT than PTC. Hashimoto thyroiditis may play an inhibitory role in the occurrence of PTC, and the presence of HT is a protective factor for PTC.
桥本甲状腺炎(HT)合并甲状腺乳头状癌(PTC)在临床实践中较为常见,可能对患者健康构成严重威胁。目前尚不确定HT是PTC的危险因素还是保护因素。本研究旨在回顾性探讨HT对PTC生物学行为的影响。
本研究共纳入200例患者。其中,100例无HT的PTC患者作为对照组(PTC组),100例诊断为PTC合并HT的患者作为实验组(HT+PTC组)。分别对以下数据进行计数和分析:(1)患者的基本临床病理特征;(2)术后甲状腺功能指标;(3)血液生化指标;(4)肝功能指标;(5)组织病理学报告。
与PTC组相比,PTC+HT组女性占比更高(P<0.05)。此外,中央淋巴结转移率、颈部淋巴结转移数量及侧方颈部淋巴结转移率均显著降低(P<0.05)。甲状腺功能指标中的甲状腺过氧化物酶抗体(TPOAb)、促甲状腺激素(TSH)及甲状腺球蛋白抗体(TGAb)显著升高,而甲状腺球蛋白(TG)值显著降低(P<0.05)。肝功能指标中的碱性磷酸酶(ALP)水平显著降低,而乳酸脱氢酶(LDH)水平显著升高(P<0.05)。病理检查显示,淋巴细胞滤泡性间质中有大量单核细胞浸润。超声检查中,边界清晰度较低。
女性可能比男性更容易患PTC或PTC合并HT。PTC+HT组中55岁以下患者的占比高于PTC组。桥本甲状腺炎可能对PTC的发生起抑制作用,HT的存在是PTC的保护因素。